Author: Mike Moore

DNAstack announces the launch of Instruments, a new feature that streamlines genomic data analysis in the cloud through direct integration with sequencing instruments. Revealed at the American Society of Human Genetics (ASHG) Annual Meeting in Denver, Instruments makes it easier and faster for scientists to go from sequences to solves.

The HiFi Solves Sub-fertility Consortium integrates DNAstack’s federated data platform, the world’s first solution to enable the creation and analysis of global federated networks of data in compliance with industry standards set by the Global Alliance for Genomics & Health.

The Aligning Science Across Parkinson’s (ASAP) initiative has collaborated with DNAstack, The Michael J. Fox Foundation, Verily, and DataTecnica to launch the ASAP Collaborative Research Network Cloud. This platform, powered by DNAstack’s Omics AI, serves to unite data analysis efforts across the global research community and accelerate the path for a cure to Parkinson’s.

As AI evolves to deliver more powerful experiences by learning from our data, it is important to implement safeguards that ensure we are protecting personal privacy. By building AI with strict requirements around the protection of personal privacy, we can develop new technologies in a safe, ethical, and responsible way for the benefit of society.

Autism Speaks’ MSSNG database, the world’s largest autism whole-genome dataset powered by DNAstack software, recently expanded to include an additional 2,489 fully sequenced genomes in the project’s cloud-based dataset. Genomic data is now available for 13,801 individuals, including over 6,000 autistic people and over 7,000 of their family members.

Target ALS, a nonprofit organization that breaks down barriers to accelerate research for Amyotrophic Lateral Sclerosis (ALS), has added a Natural History Study Collection to their recently launched data platform powered by Omics AI. The platform provides no-strings-attached access to comprehensive datasets and analysis tools to fuel discovery of treatments and biomarkers for ALS.

DNAstack is proud to announce its Bronze sponsorship with the Vector Institute, a globally-renowned AI Institute that empowers researchers, businesses and governments, to develop and adopt AI responsibly. This union between industry and academia will serve to amplify the shared goal of accelerating AI-based innovation in Canada.

In this seminar hosted by Australian Genomics, in discussion with Managing Director Tiffany Boughtwood, DNAstack CEO Marc Fiume covers the latest in genomics and health data standards, interoperability, federated insights, and AI that when combined together can enable breakthrough discoveries in precision health.

Target ALS, a nonprofit organization that breaks down barriers to accelerate research for Amyotrophic Lateral Sclerosis (ALS), has launched a first-of-its-kind data portal to provide no-strings-attached access to comprehensive datasets and analysis tools to fuel discovery of treatments and biomarkers for ALS.

Today, we’re excited to announce a new ISO standard, Requirements for interoperable systems for genomic surveillance.Genomic surveillance combined with rapid realtime data sharing is the most important tool we have for detecting and stopping the spread of infectious diseases, like COVID.

Workflows makes it easier and safer for scientists to discover and run trusted, high-quality, reproducible computational pipelines for analyzing omics data. The marketplace includes a curated collection of best practices pipelines for processing data from popular sequencing instrument manufacturers, including PacBio, Illumina, and Oxford Nanopore. Workflows integrates with Workbench, a workflow execution manager by DNAstack, unifying the experience of performing omics data analyses across multiple sequencing instruments and cloud computing platforms.

Toronto, Ontario — DNAstack today launched Omics AI, a revolutionary new software suite for omics and health research.

Omics AI makes scientific discoveries faster and more powerful by enabling insights across federated networks of data, in compliance with open standards by the Global Alliance for Genomics & Health (GA4GH). The system is being used by world leading pharmaceutical companies, hospitals, universities, patient advocacy groups, funders, sequencing facilities, government agencies, and consortiums to grow collaborative networks in diverse areas of research.

DNAstack CEO Dr. Marc Fiume speaks with Geraldine Van der Auwera and Michael de la Maza about the company’s products and vision for the future of genomics and health research.

DNAstack CEO Marc Fiume accepts the LSO Company of the Year Award, introduced by Dr. Catalina Lopez-Correa, CSO at Genome Canada.

Neuroscience AI will enable researchers to make discoveries from larger and more diverse datasets than ever before.

Toronto, Ontario — DNAstack and partners today launched Neuroscience AI, a new federated platform for collaborative neuroscience research. By enabling privacy-preserving AI-powered insights across distributed networks of data, Neuroscience AI will enable researchers to make discoveries from larger and more diverse datasets than ever before. The platform is being used to advance collaborative research in autism by connecting global members of the Autism Sharing Initiative.

The new project will help expand federated, AI-powered insights across distributed networks of genomics and health data. 

Toronto, Ontario — Today, a Canadian consortium led by DNAstack is announcing the launch of a new project to expand the development of a software platform to enable federated, AI-powered insights across networks of genomics and health data. The Canadian Platform for Genomics & Precision Health (CP4GPH) is a $14.5M initiative co-funded by Digital that brings together domain experts with a shared vision to deliver better outcomes for Canadians by making it easier to connect and analyze exponentially growing volumes of distributed genomics and health data. The project builds upon the multi-award-winning software platform developed by its partners as part of previous collaborations.

Award recognizes Toronto company’s global impact on genomics and health research.Toronto, Ontario — Today DNAstack was named 2023 Company of the Year by Life Sciences Ontario (LSO). The award celebrates DNAstack’s breakthrough software platform, which enables AI-powered insights across distributed genomics and health data. The platform is being used to support global pandemic surveillance and to advance better outcomes in neuroscience, oncology, and rare disease. The LSO Company of the Year award is given to an outstanding Ontario-based company that has demonstrated strong leadership in advancing innovative technology in the life sciences.

David Miller, PacBio VP of product marketing, highlighted the company’s partnerships, including with Hamilton, Miroculus, the Broad Institute, Twist Biosciences, Google Health, DNAnexus, and DNAstack, for various companion offerings to enhance its sequencing workflow.

Publication in Cell on the genomic architecture of autism from comprehensive genomic analysis of over 11,000 individuals.

DNAstack CEO Marc Fiume presents a vision for an Internet for Pandemic Surveillance at the 10th Plenary Meeting of the Global Alliance for Genomics & Health (GA4GH) in Barcelona, Spain.

DNAstack CEO Dr. Marc Fiume spoke with Angie Seth of CTV on his vision for an Internet for Pandemic Surveillance.

DNAstack drives medical breakthroughs with its federated data discovery and analysis platform built on open standards.  The company was selected for establishing federated data networks and powering insights in pandemic surveillance, neuroscience, rare disease, and oncology.

DNAstack today announced Viral AI, a federated network for genomic variant surveillance and infectious disease research. Viral AI was designed to deliver equitable access to software infrastructure, accelerate international data sharing, and empower scientists and public health officials with globally representative datasets they need to mitigate current and future infectious disease outbreaks.

Our world is constantly changing and at its core, innovation is really about responding to change in a new, creative way. It requires courage, conviction, resilience, the support of a community of collaborators, and innovation-oriented policies in order to succeed.Digital technologies are driving much of this change, rapidly outpacing our traditional systems and infrastructure. It’s more important than ever that we bolster innovation to foster effective and sustainable health care, as well as economic growth.

A coalition of researchers and healthcare providers in Canada and beyond are building what they believe to be the first global, federated network for sharing genomics and clinical data to support advances in research and patient care for autism (Subscriber content). 

Canada’s Digital Technology Supercluster and DNAstack today announced the Autism Sharing Initiative, a new project to build the first federated, global network for sharing genomics and clinical data to accelerate research with the hopes of developing precision healthcare approaches for autistic individuals.

Genome Canada launched the Canadian VirusSeq Data Portal today to track the evolving COVID-19 pandemic across Canada. 

Genome Canada, in partnership with the Government of Canada, is pleased to announce the development of a new Canadian SARS-CoV-2 Data Portal.